Blog
RSS FeedPosted by Michael Wonder on 26 Nov 2025
US negotiates lower prices for Ozempic and 14 other drugs
November 25, 2025 - Price cuts will save Medicare an estimated $12 billion in prescription drug spending. ...
Posted by Michael Wonder on 21 Nov 2025
Taiho Oncology, Taiho Pharmaceutical and Cullinan Therapeutics initiate rolling submission of new drug application to US FDA for zipalertinib for treatment of locally advanced or metastatic non-small cell lung cancer with EGFR exon 20 insertion mutations
20 November 2025 - Taiho Oncology, Taiho Pharmaceutical and Cullinan Therapeutics today announced the companies have initiated the rolling submission ...
Posted by Michael Wonder on 21 Nov 2025
US pharma ramps up attack on Australia’s ‘discriminatory’ drug pricing
20 November 2025 - The US pharmaceutical industry is increasing pressure on Donald Trump to take action against the PBS, ...
Posted by Michael Wonder on 19 Nov 2025
Lynkuet (elinzanetant) approved in the EU for the treatment of moderate to severe vasomotor symptoms associated with menopause or endocrine therapy for breast cancer
19 November 2025 - The European Commission has granted marketing authorisation in the European Union for elinzanetant, under the brand name ...
Posted by Michael Wonder on 15 Nov 2025
FDA’s new plausible mechanism pathway
12 November 2025 - Personalised therapies hold tremendous promise but challenge traditional models of drug and biologic development. ...
Posted by Michael Wonder on 08 Nov 2025
Novo Nordisk announces agreement with the US Administration to bring GLP-1s to more Americans at a lower cost
6 November 2025 - Today it was announced that Novo Nordisk has agreed with the US Administration to lower drug prices ...
Posted by Michael Wonder on 07 Nov 2025
The FDA is a mess, but don’t blame it for everything
6 November 2025 - Biohaven and Uniqure fault agency volatility for setbacks. The reality may be more complicated. ...
Posted by Michael Wonder on 07 Nov 2025
CMS announces new drug payment model to strengthen Medicaid and better serve vulnerable Americans
6 November 2025 - The CMS is tackling high drug prices and protecting the American taxpayers through a landmark Innovation Center ...
Posted by Michael Wonder on 30 Oct 2025
FDA moves to accelerate biosimilar development and lower drug costs
29 October 2025 - The US FDA today announced significant action to make it faster and less costly to develop ...
Posted by Michael Wonder on 27 Oct 2025
Flaws in the FDA’s new priority voucher program
25 October 2025 - A new FDA program is being promoted as a tool to facilitate the development and approval of ...
Posted by Michael Wonder on 17 Oct 2025
Merck announces unprecedented agreement with US Government to expand access to IVF therapies
16 October 2025 - Merck announced today that EMD Serono, the healthcare business of Merck in the US and Canada, ...
Posted by Michael Wonder on 10 Oct 2025
AstraZeneca announces historic agreement with US Government to lower the cost of medicines for American patients
10 October 2025 - AstraZeneca today announces a historic agreement with President Donald J. Trump’s administration to lower the cost ...
Posted by Michael Wonder on 09 Oct 2025
Donald Trump’s cure for drug prices is worse than the disease
2 October 2025 - Few things infuriate Americans as much as drug prices. Republicans and Democrats alike agree that poorly patients ...
Posted by Michael Wonder on 05 Oct 2025
Why Pfizer’s Trump deal is good news for all of big pharma
2 October 2025 - The company’s accord with the president clears a cloud over the whole sector. ...
Posted by Michael Wonder on 01 Oct 2025
White House unveils ‘TrumpRx’ drug buying site and a Pfizer pricing deal
30 September 2025 - The company says it gains a three year grace period to exempt it from national-security-related tariffs. ...